Rheumatoid Arthritis Resource Center
The Great Debate at ACR Convergence 2020 is: Janus Kinase Inhibitors Should/Should Not Be Used Before Biologics After Methotrexate Failure in RA. No need to hang in suspense. In this resource center, you’ll get the pros and cons, and highlights from other important sessions on rheumatoid arthritis (RA). Plus, you can explore our collection of research reviews, case reports and clinical articles on advances in the diagnosis and management of RA.
VIEW
ACR Convergence 2022 Closing Session Discusses Research Highlights
3 AC&R Study Summaries: Treat to Target in Gout, Response to Biologics in Patients with JIA, & Rehabilitation Dose in Adults with RA
A Look Back at the First Use of Cortisone in Rheumatoid Arthritis
An Integrative Approach to the Treatment of Rheumatoid Arthritis
String of Pearls: Lessons in Rheumatoid Arthritis
To Treat or Not to Treat? The Great Debate on Treatment of Subclinical Rheumatoid Arthritis
Clinical Rheumatology Year in Review—2022
Patients Fight Against Dark Days & Find Ways to Cope
Difficult-to-Treat RA Definition & Management Considerations
- 1
- 2
- 3
- …
- 68
- Next Page »